Ticker

July's GVAS Dogs list highlights ten fair-priced, high-yield large-cap stocks, including IRSA Inversiones, Weibo, Verizon, and AT&T, as ideal buys. Analyst targets project average net gains of 40.39% for the top ten GVAS stocks by July 2027, with risk profiles generally below market volatility. The dividend dogcatcher strategy favors stocks whose $1K dividend income exceeds share price, with 36 of 54 GVAS stocks…

Russell 2000 & 3000 Maybe Hold Forever Stocks (MHFS) featured high (>4%) dividends, attractive or neutral ratings, >2-year dividend history, and positive cash flow per YCharts stock screener. The resulting list targets investors who “want to simply focus on profitable stocks without the fuss and bother of anything but an annual review and rebalance." 38 MHFS, from the Russell 2000/3000 2026 batch screened as of…

5 low price-to-sales stocks passed a value screen that combines valuation, debt and quality metrics to highlight potential upside opportunities.

Nu Skin Enterprises (NUS) faces low profitability and macro-driven sales headwinds, with limited recession resistance and weak operating cash flow. The India market expansion is a key strategic focus, but execution risks are high and infrastructure investments will elevate fixed costs. NUS's working capital intensity pose cash flow risks even in growth, despite low net debt and recent refinancing extending…

EL, HELE, NUS, KVUE and IPAR stand out as beauty and cosmetics stocks backed by growth strategies for 2H 2026.